Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases

The cell division cycle 25 phosphatases (CDC25A, B, and C; E.C. 3.1.3.48) are key regulator of the cell cycle in human cells. Their aberrant expression has been associated with the insurgence and development of various types of cancer, and with a poor clinical prognosis. Therefore, CDC25 phosphatase...

Full description

Bibliographic Details
Main Authors: Emilie Evain-Bana, Lucie Schiavo, Christophe Bour, Don Antoine Lanfranchi, Simone Berardozzi, Francesca Ghirga, Denyse Bagrel, Bruno Botta, Gilles Hanquet, Mattia Mori
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2016.1238364
_version_ 1818502992911925248
author Emilie Evain-Bana
Lucie Schiavo
Christophe Bour
Don Antoine Lanfranchi
Simone Berardozzi
Francesca Ghirga
Denyse Bagrel
Bruno Botta
Gilles Hanquet
Mattia Mori
author_facet Emilie Evain-Bana
Lucie Schiavo
Christophe Bour
Don Antoine Lanfranchi
Simone Berardozzi
Francesca Ghirga
Denyse Bagrel
Bruno Botta
Gilles Hanquet
Mattia Mori
author_sort Emilie Evain-Bana
collection DOAJ
description The cell division cycle 25 phosphatases (CDC25A, B, and C; E.C. 3.1.3.48) are key regulator of the cell cycle in human cells. Their aberrant expression has been associated with the insurgence and development of various types of cancer, and with a poor clinical prognosis. Therefore, CDC25 phosphatases are a valuable target for the development of small molecule inhibitors of therapeutic relevance. Here, we used an integrated strategy mixing organic chemistry with biological investigation and molecular modeling to study novel quinonoid derivatives as CDC25 inhibitors. The most promising molecules proved to inhibit CDC25 isoforms at single digit micromolar concentration, becoming valuable tools in chemical biology investigations and profitable leads for further optimization.
first_indexed 2024-12-10T21:17:46Z
format Article
id doaj.art-9849d8058a8e460d947b419399a0e753
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-10T21:17:46Z
publishDate 2017-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-9849d8058a8e460d947b419399a0e7532022-12-22T01:33:14ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742017-01-0132111311810.1080/14756366.2016.12383641238364Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatasesEmilie Evain-Bana0Lucie Schiavo1Christophe Bour2Don Antoine Lanfranchi3Simone Berardozzi4Francesca Ghirga5Denyse Bagrel6Bruno Botta7Gilles Hanquet8Mattia Mori9Université de LorraineUniversité de StrasbourgUniversitéUniversité de StrasbourgSapienza University of RomaCenter for Life Nano Science@SapienzaUniversité de LorraineSapienza University of RomaUniversité de StrasbourgCenter for Life Nano Science@SapienzaThe cell division cycle 25 phosphatases (CDC25A, B, and C; E.C. 3.1.3.48) are key regulator of the cell cycle in human cells. Their aberrant expression has been associated with the insurgence and development of various types of cancer, and with a poor clinical prognosis. Therefore, CDC25 phosphatases are a valuable target for the development of small molecule inhibitors of therapeutic relevance. Here, we used an integrated strategy mixing organic chemistry with biological investigation and molecular modeling to study novel quinonoid derivatives as CDC25 inhibitors. The most promising molecules proved to inhibit CDC25 isoforms at single digit micromolar concentration, becoming valuable tools in chemical biology investigations and profitable leads for further optimization.http://dx.doi.org/10.1080/14756366.2016.1238364CDC25enzyme inhibitorsquinonoidorganic synthesismolecular modeling
spellingShingle Emilie Evain-Bana
Lucie Schiavo
Christophe Bour
Don Antoine Lanfranchi
Simone Berardozzi
Francesca Ghirga
Denyse Bagrel
Bruno Botta
Gilles Hanquet
Mattia Mori
Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
Journal of Enzyme Inhibition and Medicinal Chemistry
CDC25
enzyme inhibitors
quinonoid
organic synthesis
molecular modeling
title Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
title_full Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
title_fullStr Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
title_full_unstemmed Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
title_short Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
title_sort synthesis biological evaluation and molecular modeling studies on novel quinonoid inhibitors of cdc25 phosphatases
topic CDC25
enzyme inhibitors
quinonoid
organic synthesis
molecular modeling
url http://dx.doi.org/10.1080/14756366.2016.1238364
work_keys_str_mv AT emilieevainbana synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT lucieschiavo synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT christophebour synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT donantoinelanfranchi synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT simoneberardozzi synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT francescaghirga synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT denysebagrel synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT brunobotta synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT gilleshanquet synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases
AT mattiamori synthesisbiologicalevaluationandmolecularmodelingstudiesonnovelquinonoidinhibitorsofcdc25phosphatases